Stock Research for FATE

FATE
Current Price

$10.7402


Latest Update: 2018-02-21 14:07:00

High
$ 10.7800
Low
$ 10.7402
Close
$ 10.7500
Volume
2300
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

FATE Stock Chart & Research Data

The FATE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FATE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


FATE Due diligence Resources & Stock Charts

The FATE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View FATE Detailed Price Forecast - CNN Money CNN View FATE Detailed Summary - Google Finance
Yahoo View FATE Detailed Summary - Yahoo! Finance Zacks View FATE Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View FATE Trends & Analysis - Trade-Ideas Barrons View FATE Major Holders - Barrons
NASDAQ View FATE Call Transcripts - NASDAQ Seeking View FATE Breaking News & Analysis - Seeking Alpha
Spotlight View FATE Annual Report - CompanySpotlight.com OTC Report View FATE OTC Short Report - OTCShortReport.com
TradeKing View FATE Fundamentals - TradeKing Charts View FATE SEC Filings - Bar Chart
WSJ View Historical Prices for FATE - The WSJ Morningstar View Performance/Total Return for FATE - Morningstar
MarketWatch View the Analyst Estimates for FATE - MarketWatch CNBC View the Earnings History for FATE - CNBC
StockMarketWatch View the FATE Earnings - StockMarketWatch MacroAxis View FATE Buy or Sell Recommendations - MacroAxis
Bullish View the FATE Bullish Patterns - American Bulls Short Pains View FATE Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View FATE Stock Mentions - StockTwits PennyStocks View FATE Stock Mentions - PennyStockTweets
Twitter View FATE Stock Mentions - Twitter Invest Hub View FATE Investment Forum News - Investor Hub
Yahoo View FATE Stock Mentions - Yahoo! Message Board Seeking Alpha View FATE Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for FATE - SECform4.com Insider Cow View Insider Transactions for FATE - Insider Cow
CNBC View FATE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for FATE - OTC Markets
Yahoo View Insider Transactions for FATE - Yahoo! Finance NASDAQ View Institutional Holdings for FATE - NASDAQ


Stock Charts

FinViz View FATE Stock Insight & Charts - FinViz.com StockCharts View FATE Investment Charts - StockCharts.com
BarChart View FATE Stock Overview & Charts - BarChart Trading View View FATE User Generated Charts - Trading View


Latest Financial News for FATE

Fate Therapeutics Announces First Subject Treated with FATE-NK100 in DIMENSION Study for Advanced Solid Tumors
Posted on Tuesday February 20, 2018

SAN DIEGO, Feb. 20, 2018-- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced ...


Fate Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Posted on Monday February 12, 2018

SAN DIEGO, Feb. 12, 2018-- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders, announced ...


With A -16.46% Earnings Drop, Is Fate Therapeutics Inc’s (NASDAQ:FATE) Performance A Concern?
Posted on Monday February 05, 2018

Examining Fate Therapeutics Inc’s (NASDAQ:FATE) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations,Read More...


Research Report Identifies Fate Therapeutics, A. Schulman, Celadon Group, Egalet, Meredith, and HCP with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Thursday January 25, 2018

NEW YORK, Jan. 25, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fate ...


Fate Therapeutics Announces First Subject Treated with FATE-NK100 in DIMENSION ...
GlobeNewswire (press release) - Feb 20, 2018
SAN DIEGO, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that the ...
Which insiders are trading Fate Therapeutics, Inc. (FATE)? - Post Analyst
Can Fate Therapeutics, Inc. (FATE)'s Tomorrow Be Different? The Stock ... - KL Daily

Here's Why Fate Therapeutics Rose as Much as 18% Today
Motley Fool - Jan 23, 2018
Fate Therapeutics can't really be compared to Juno Therapeutics, as it's still in the earliest stages of development, but the tiny peer has taken a shotgun approach to immunotherapy and cell therapy.

Headed For A Crash? – Cara Therapeutics, Inc. (CARA), Fate Therapeutics, Inc ...
Post Analyst - 7 hours ago
Cara Therapeutics, Inc. is maintained at an average buy rating by 6 stock analysts, and there are at least 21.43% of shares outstanding that are currently legally short sold.
Fate Therapeutics (FATE) Shares Moving 15.05% On Volume - Jonesboro Recorder

Comparing Top Moving Stocks Vale SA (VALE), Fate Therapeutics, Inc. (FATE)
StockNewsGazette - Feb 20, 2018
The shares of Vale S.A. have increased by more than 15.45% this year alone. The shares recently went down by -0.07% or -$0.01 and now trades at $14.12.

Enter a stock symbol to view the stock details.